Keyphrases
Breast Carcinogenesis
100%
Post-translational Modification
100%
PARP Inhibitor (PARPi)
100%
Triple-negative Breast Cancer
62%
Synergize
37%
Metastasis
37%
Poly(ADP-ribose)
25%
Genome Stability
25%
Olaparib
25%
Talazoparib
25%
Breast Cancer Patients
25%
Breast Cancer Treatment
25%
Breast Cancer Progression
25%
Breast Cancer Susceptibility Gene 1 (BRCA1)
25%
Signaling Nodes
12%
HER2-targeted Therapy
12%
Glint
12%
Chromatin Recruitment
12%
Tumor Organoids
12%
Metastatic Breast Cancer
12%
Drug Sensitivity
12%
Physiological Relevance
12%
Patient-derived Xenograft
12%
Clinical Significance
12%
Tumor
12%
Small Molecule Inhibitors
12%
DNA Repair
12%
Genomic Instability
12%
Transcriptional Activity
12%
Tumor Progression
12%
Chromatin
12%
Poor Prognosis
12%
DNA Damage Response
12%
Oncogenesis
12%
Breast Cancer
12%
Triple-negative Breast Cancer Cells
12%
Tumor Patients
12%
Human Breast Tumor
12%
Medicine and Dentistry
Calcium Ion
100%
Protein Processing
100%
Breast Carcinogenesis
100%
Triple Negative Breast Cancer
46%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
38%
Metastatic Carcinoma
30%
Breast Tumor
23%
Tumor Progression
23%
PARP Inhibitor
23%
Genomic Instability
23%
Olaparib
15%
BRCA1
15%
Talazoparib
15%
Cancer Therapy
15%
Adenosine Diphosphate
15%
DNA Repair
7%
Organoid
7%
Xenograft
7%
Carcinogenesis
7%
Cancer Cell
7%
DNA Damage Response
7%
Breast Cancer
7%
Neoplasm
7%
Drug Sensitivity
7%
Targeted Therapy
7%
Hope
7%
Pharmacology, Toxicology and Pharmaceutical Science
Calcium Ion
100%
Breast Carcinogenesis
100%
Triple Negative Breast Cancer
46%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
38%
Tumor Growth
23%
Breast Tumor
23%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
23%
Talazoparib
15%
Olaparib
15%
Adenosine Diphosphate
15%
Breast Cancer
7%
Carcinogenesis
7%
Neoplasm
7%